Compare WVE & HG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WVE | HG |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Singapore | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2015 | 2023 |
| Metric | WVE | HG |
|---|---|---|
| Price | $12.65 | $30.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $30.44 | $29.86 |
| AVG Volume (30 Days) | ★ 3.2M | 578.8K |
| Earning Date | 03-03-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 4.19 |
| Revenue | $109,230,000.00 | ★ $2,745,461,000.00 |
| Revenue This Year | N/A | $25.37 |
| Revenue Next Year | $16.10 | $0.75 |
| P/E Ratio | ★ N/A | $7.39 |
| Revenue Growth | ★ 103.75 | 21.12 |
| 52 Week Low | $5.28 | $16.80 |
| 52 Week High | $21.73 | $31.60 |
| Indicator | WVE | HG |
|---|---|---|
| Relative Strength Index (RSI) | 41.05 | 77.79 |
| Support Level | $12.51 | $29.23 |
| Resistance Level | $14.15 | $31.60 |
| Average True Range (ATR) | 0.76 | 0.86 |
| MACD | -0.04 | 0.31 |
| Stochastic Oscillator | 8.29 | 85.29 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Hamilton Insurance Group Ltd is a specialty insurance and reinsurance company. It operates globally, with underwriting operations in London, Dublin, Bermuda, and the United States. It operates three principal underwriting platforms (Hamilton Global Specialty, Hamilton Select and Hamilton Re) that are categorized into two reporting business segments: International and Bermuda.